The Volccine team is forged by worldwide well-known professors and researchers with many years of rich experience in gene delivery research field and pharmaceutical industry.
Volccine is committed to develop new gene (nucleic acid) related medicines. Our focus is to use our advanced gene delivery platform and the manufacturing facilities to address infectious diseases and cancers.
To create advanced delivery vehicles, to deliver transformative new generation gene medicines for patients.
Volccine locates in the International Medical Park in Pudong New Area, Shanghai, where a cluster of cutting-edge biotechnology companies assembles to explore the now frontiers of cell and gene therapies.
· Advanced gene delivery platform able to deliver all type of nucleic acids with tailored solution.
· World’s leading independent intellectual property rights on non-LNP delivery systems.
· Close collaboration with major pharmaceutical companies to carry out multiple pipelines, ensuring future massive production and successful product launch.
· Highly professional core specialist team with more than 10 years of experience in the fields of nucleci acid research and pharmaceutical industry.
The company is located in Shanghai Pudong New Area International Medical Park, which focuses on cell and gene therapy, gene sequencing and molecular diagnosis, cell and gene therapy CRO/CDMO and other directions, and will be built into a cell and gene industry cluster with global influence. The park focusing cells and gene therapies, gene sequencing and molecular diagnosis, cells and gene treated cro / cdmo, etc., will build cells with global influence and genetic industries.
Shanghai Pudong New Area International Medical Park
?Shanghai Volccine Biologics Co., Ltd. All rights reserved Shanghai ICP 2022012584-1